Communicable Diseases Act, B.E. 2558 (2015) · communicable disease under surveillance

Notification of the Ministry of Public Health Re: The names and presenting symptoms of communicable diseases under surveillance, (No.2), B.E. 2565 (2022)

Published in the Government Gazette 8 July B.E. 2565 (2022); in force from 9 July B.E. 2565 (2022)

Whereas it is expedient to announce Monkeypox as a communicable disease under surveillance pursuant to the Communicable Diseases Act B.E. 2558 (2015), for the purpose of surveillance, prevention, and control of communicable diseases.

By virtue of section 5 and section 6 (1) of the Communicable Diseases Act, B.E. 2558 (2015), the Minister of Public Health by and with the advice of the National Communicable Disease Committee, hereby issues the following Notification:

Clause 1. This Notification is called “Notification of the Ministry of Public Health Re: the names and presenting symptoms of communicable diseases under surveillance (No.2), B.E. 2565 (2022).

Clause 2. This Notification shall come into force on the day following the date of its publication in the Government Gazette.

Clause 3. The following provision shall be added as item 56 of clause 4 of the Notification of the Ministry of Public Health Re: the names and presenting symptoms of communicable diseases under surveillance, B.E. 2562 (2019)

“(56) Monkeypox is characterized by a fever, headache, swollen lymph nodes, sore throat, and the presence of a rash or lesions in the form of vesicles or pustules on the skin, which may appear on the head, trunk, genital and perianal areas, arms, or legs. In some cases, lesions may also appear on the palms of the hands or soles of the feet.”

Announced on 30th Day of June B.E. 2565 (2022)

Anutin Charnvirakul

Minister of Public Health

Unofficial English translation by the Division of Legal Affairs, Department of Disease Control (August 2025), book page 71; the Thai text prevails.